Read the article: Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions. Discuss how clinical development plays a role in reimbursement of gene therapies. Discuss how regulatory requirements play a role in reimbursement of gene therapies. Provide your opinion on if and how reimbursement of gene therapies should be provided. What process would you design to determine if a gene therapy should be reimbursed? Here is the article: : van Overbeeke E, Michelsen S, Toumi M, Stevens H, Trusheim M, Huys I, Simoens S. Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions. Drug Discov Today. 2021 Feb;26(2):399-415. doi: 10.1016/j.drudis.2020.11.024. Epub 2020 Nov 24. PMID: 33242695. https://pubmed.ncbi.nlm.nih.gov/33242695/
